Founded in 2013 in Montréal, Quebec, Canada, Emerillon Capital invests in series A, series B, series D, and venture rounds. Its portfolio includes companies such as PreciThera, Q4, Maluuba, ScribbleLive, and Acquisio. With three notable exits, including ScribbleLive, Acquisio, and Maluuba, Emerillon Capital has made five investments as of March 2020. The fund primarily invests in the IT sector, targeting investments ranging from $0.5 million to $5 million per company, and aims to make 7 to 9 investments.